Hibernating myocardium and coronary artery bypass surgery

Heart and Metabolism

Volumn , Issue 29, 2006, Pages

  Hunt, Ian ^a   Ogunyiluka, Tunde ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Coronary artery disease; Hibernating myocardium; Myocardial stunning; Surgical revascularization

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; BISOPROLOL; DOBUTAMINE; FLUCLOXACILLIN; GLYCERYL TRINITRATE;

AGED; ARTICLE; BONE INFECTION; CASE REPORT; CELL VIABILITY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FUNCTIONAL ASSESSMENT; GENERAL CONDITION IMPROVEMENT; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CELL; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPOKINESIA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MYOCARDIAL HIBERNATION; NON INVASIVE PROCEDURE; PATIENT SELECTION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; ST SEGMENT DEPRESSION; STANDARD; STRESS ECHOCARDIOGRAPHY; SYMPTOM; THORAX PAIN;

EID: 33645762328     PISSN: 15660338     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Bax JJ, Poldermans D, van der Wall EE. Evaluation of hibernating myocardium. Heart. 2004;90:1239-1240.
2. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation. 1982;66:1146-1149.
3. Rahimtoola SH. The hibernating myocardium. Am Heart J. 1989;117:211-221.
4. Hernandez-Pampaloni M, Bax JJ, Morita K, Dutka DP, Camici PG. Incidence of stunned, hibernating and scarred myocardium in ischaemic cardiomyopathy. Eur J Nucl Med Mol Imaging. 2005;32:314-321.
5. Cabin HS, Clubb KS, Vita N, Zaret BL. Regional dysfunction by equilibrium radionuclide angiocardiography: a clinicopathologic study evaluating the relation of degree of dysfunction to the presence and extent of myocardial infarction. J Am Coll Cardiol. 1987;10:743-747.
6. Luss H, Schafers M, Neumann J, et al. Biochemical mechanisms of hibernation and stunning in the human heart. Cardiovasc Res. 2002;56:411-421.
7. Cheirif J. Diagnosis of myocardial stunning: a new use for myocardial contrast and dobutamine echocardiography. Am J Card Imaging. 1995;9:261-268.
8. Yao SS, Chaudhry FA. Assessment of myocardial viability with dobutamine stress echocardiography in patients with ischemic left ventricular dysfunction. Echocardiography. 2005;22:71-83.
9. Rocchi G, Poldermans D, Bax JJ, et al. Usefulness of the ejection fraction response to dobutamine infusion in predicting functional recovery after coronary artery bypass grafting in patients with left ventricular dysfunction. Am J Cardiol. 2000;85:1440-1444.
10. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39:1151-1158.
11. Cheirif J, Murgo JP. Assessment of myocardial viability by dobutamine echocardiography. Coron Artery Dis. 1995;6:600-605.
12. Sawada SG, Lewis SJ, Foltz J, et al. Usefulness of rest and low-dose dobutamine wall motion scores in predicting survival and benefit from revascularization in patients with ischemic cardiomyopathy. Am J Cardiol. 2002;89:811-816.
13. Hausmann H, Meyer R, Siniawski H, et al. Factors excercising an influence on recovery of hibernating myocardium after coronary artery bypass grafting. Eur J Cardiothorac Surg. 2004;26:89-95.
14. Westaby S. Coronary revascularization in ischemic cardiomyopathy. Surg Clin North Am. 2004;84:179-199.
15. Rizzello V, Poldermans D, Biagini E, et al. Comparison of long-term effect of coronary artery bypass grafting in patients with ischemic cardiomyopathy with viable versus nonviable left ventricular myocardium. Am J Cardiol. 2004;94:757-760.
16. Rizzello V, Poldermans D, Biagini E, et al. Improvement of stress LVEF rather than rest LVEF after coronary revascularisation in patients with ischaemic cardiomyopathy and viable myocardium. Heart. 2005;91:319-323.
17. Bax JJ, Poldermans D, Elhendy A, et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol. 1999;34:163-169.
18. Marwick TH, Zuchowski C, Lauer MS, Secknus MA, Williams J, Lytle BW. Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability. J Am Coll Cardiol. 1999;33:750-758.
19. Meluzin J, Cerny J, Frelich M, et al. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. Investigators of this Multicenter Study. J Am Coll Cardiol. 1998;32:912-920.
20. Meluzin J, Cerny J, Spinarova L, et al. Prognosis of patients with chronic coronary artery disease and severe left ventricular dysfunction. The importance of myocardial viability. Eur J Heart Fail. 2003;5:85-93.
21. Schinkel AF, Poldermans D, Rizzello V, et al. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization? J Thorac Cardiovasc Surg. 2004;127:385-390.
22. Bax JJ, Schinkel AF, Boersma E, et al. Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis. Circulation. 2004;110:II18-II22.
23. Marwick TH. The viable myocardium: epidemiology, detection, and clinical implications. Lancet. 1998;351:815-819.